Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eberhardt KA, Jung V, Knops E, Heger E, Wirtz M, Steger G, et al. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality. Bone Marrow Transpl. 2023;58:639–46.

Article  CAS  Google Scholar 

Limaye AP, Babu TM, Boeckh M. Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation. Clin Microbiol Rev. 2020;34:e00043–19.

Article  PubMed  PubMed Central  Google Scholar 

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377:2433–44.

Article  CAS  PubMed  Google Scholar 

Zamora D, Duke ER, Xie H, Edmison BC, Akoto B, Kiener R, et al. Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation. Blood. 2021;138:34–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Effectiveness of Letermovir for Cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: a global systematic review. J Am Pharm Assoc 2023. 2003;63:1138–49.

Article  Google Scholar 

Sourisseau M, Faure E, Behal H, Chauvet P, Srour M, Capes A, et al. The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients. Blood Adv. 2023;7:856–65.

Article  CAS  PubMed  Google Scholar 

Liu LW, Yn A, Gao F, Olson M, Crain M, Abboud R, et al. Letermovir Discontinuation at Day 100 after allogeneic stem cell transplant is associated with increased CMV-related mortality. Transpl Cell Ther. 2022;28:510.e1–e9.

Article  CAS  Google Scholar 

Vyas A, Raval AD, Kamat S, LaPlante K, Tang Y, Chemaly RF. Real-world outcomes associated with Letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies. Open Forum Infect Dis. 2023;10:ofac687.

Article  PubMed  Google Scholar